ADVERTISEMENT

European Biotechnology

1 / 4
EBM 3.2026 Autumn_cover

The autumn issue of European Biotechnology magazine asks what happens when biotech leaves Earth. Our cover story explores how microgravity could help researchers study disease, improve drug formulations … more ➔

Get a free sample copy | Abo
2 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

Get a free sample copy | Abo
3 / 4

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

Get a free sample copy | Abo
4 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

Get a free sample copy | Abo

ADVERTISEMENT

ADVERTISEMENT

Sponsored Publications

1 / 4
Celonic
Biosimilars

Perfusion for next generation biosimilars

Perfusion is here, and it is rewriting the rules of biologics and biosimilar manufacturing. What was once experimental has become industrial reality: scalable, robust, regulatorily accepted, and commercially … more ➔

2 / 4
eppendorf-new_CDMO115x65V2
CRO & CDMO

Every process is different. Not the platform.

For CDMOs, flexible upstream platforms can help streamline process ­development while maintaining reproducibility and continuity across scales. more ➔

3 / 4
Professor Jacob George, Chief Medical and Scientific Officer at the MHRA presenting his keynote speech at Phacilitate Advanced Therapies Europe, 2026
Cell & Gene Therapy

Europe’s CGT advantage at risk

Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, regulation, reimbursement, manufacturing and patient access to retain its global … more ➔

4 / 4
Ponchi Kantt-Neaz, Global Executive Business Director 3PBIOVIAN
Commercial Strategy

3PBIOVIAN appoints Ponchi Kantt-Neaz as Global Executive Business Director

The appointment of Ponchi marking an important milestone in the company’s global commercial strategy and further strengthening its commercial leadership as the company continues to expand its presence … more ➔

APPOINTMENTS

all appointments

ADVERTISEMENT

All news
newsletter_link

EVENT

BSA26-Banner-960x540
October 13 - October 14in Innsbruck

BIOTECH SUMMIT AUSTRIA 2026

On October 13–14, 2026, Innsbruck will become the meeting point for Austria’s and Europe’s biotech community. The BIOTECH SUMMIT AUSTRIA brings together leading voices from research, industry, startups, investment and policy to exchange ideas, explore trends and build new partnerships. ➔